Clinical Trial Update: Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of proton pump inhibitors on fat absorption in cystic fibrosis with pancreatic exocrine insufficiency. The study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Exocrine Insufficiency

Drugs mentioned

• Proton pump inhibitors (PPI) (proton pump inhibitors)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Pancreatic Insufficiency, Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2024-04-30